Evidence map›Paper›PMID 30530602›Full record

ArticleAntimicrobial agents and chemotherapy2019

Spreading Patterns of NDM-Producing

Yo Sugawara, Yukihiro Akeda, Hideharu Hagiya, Noriko Sakamoto, Dan Takeuchi, Rathina Kumar Shanmugakani, Daisuke Motooka, Isao Nishi, Khwar Nyo Zin, Mya Mya Aye and 3 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Carbapenem-ResistantMicroorganisms · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genomic Insights intoMicroorganisms · 2025
    Article
  8. Outbreak of NDM-5-ProducingAntibiotics (Basel, Switzerland) · 2025
    Article
  9. Genomic characterization of extended-spectrum β-lactamase-producingApplied and environmental microbiology · 2025
    Article
  10. Polyclonal carbapenemase-producingFrontiers in cellular and infection microbiology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Comparative Genomics of an Emerging Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
  15. Article
  16. First report ofMicrobiology spectrum · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yo SugawaraJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan y1yo2yo3@biken.osaka-u.ac.jp.ORCID 0000-0002-9897-3905
Yukihiro AkedaJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
Hideharu HagiyaDivision of Infection Control and Prevention, Osaka University Hospital, Suita, Japan.
Noriko SakamotoJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
Dan TakeuchiJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
Rathina Kumar ShanmugakaniDivision of Infection Control and Prevention, Osaka University Hospital, Suita, Japan.
Daisuke MotookaDepartment of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
Isao NishiLaboratory for Clinical Investigation, Osaka University Hospital, Suita, Japan.
Khwar Nyo ZinClinical Laboratory Department, Yangon General Hospital, Yangon, Myanmar.
Mya Mya AyeBacteriology Research Division, Department of Medical Research, Yangon, Myanmar.
Thuzar MyintBacteriology Research Division, Department of Medical Research, Yangon, Myanmar.
Kazunori TomonoDivision of Infection Control and Prevention, Osaka University Hospital, Suita, Japan.
Shigeyuki HamadaJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spread of carbapenemase-producing

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCarbapenemsDrug Resistance, BacterialEnterobacter cloacaeEnterobacteriaceae InfectionsEscherichia coliHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsMyanmarPlasmidsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta lactamase NDM-5, E colibeta-LactamasescarbapenemaseCarbapenemsblaNDMcarbapenemasecarbapenemsEnterobacteriaceaeMyanmarplasmid-mediated resistance

Identifiers

PMID30530602
PMCPMC6395922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.